n-(2-hydroxypropyl)methacrylamide has been researched along with Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chytil, P; Daumová, L; Etrych, T; Klener, P; Kolářová, V; Lidický, O; Pankrác, J; Pokorná, E; Šefc, L; Tušková, D | 1 |
| Chu, TW; Hartley, JM; Kopeček, J; Yang, J; Zhang, R | 1 |
2 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Lymphoma
| Article | Year |
|---|---|
Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging.
Topics: Acrylamides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Dendrimers; Doxorubicin; Drug Liberation; Female; Fluorescent Dyes; Heterografts; Humans; Hydrazones; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Lymphoma; Methacrylates; Mice; Nanocapsules; Polymerization; Polymers | 2018 |
Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system.
Topics: Acrylamides; Animals; Antigens, CD20; Apoptosis; Cell Line, Tumor; Female; Fluorescence; Humans; Immunoglobulin Fab Fragments; Lipids; Lymphoma; Membrane Lipids; Mice, Nude; Mice, SCID; Multimodal Imaging; Peptides | 2015 |